A Flagship VentureLabs Company

Seres Health

161 First Street

Cambridge, MA  02142

Tel: (617) 945-9626


Leadership:
Roger Pomerantz, MD
President & CEO


Website:
www.sereshealth.com


Information:
info@sereshealth.com

Seres Health

Flagship Partners:  Noubar Afeyan, David Berry
Initial Investment: 
2012
Status: 
Private

Seres Health is a clinical-stage therapeutics company focused on discovering and developing Ecobiotic® therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs™, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases. Seres recently announced a research agreement with Mayo Clinic and has received over $20 million in funding to date.

Noubar Afeyan and David Berry are on the Board of Directors.